Centrosomal abnormality is common in and a potential biomarker for bladder cancer
暂无分享,去创建一个
A. Sabichi | S. Lippman | H. Grossman | F. Jiang | S. Lerner | N. Caraway | J. Gu | R. Katz | Huazhong Zhang | Arnout Ruitrok | H. B. Grossman
[1] Erich A. Nigg,et al. Centrosome aberrations: cause or consequence of cancer progression? , 2002, Nature Reviews Cancer.
[2] W. Lingle,et al. Centrosome amplification and the development of cancer , 2002, Oncogene.
[3] Carol Reynolds,et al. Centrosome amplification drives chromosomal instability in breast tumor development , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[4] T. Ried,et al. Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu , 2002, Oncogene.
[5] M. Grollino,et al. Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma. , 2001, European journal of cancer.
[6] Masafumi Nakamura,et al. Stepwise Progression of Centrosome Defects Associated with Local Tumor Growth and Metastatic Process of Human Pancreatic Carcinoma Cells Transplanted Orthotopically into Nude Mice , 2001, Laboratory Investigation.
[7] L. Bubendorf,et al. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. , 2001, American journal of clinical pathology.
[8] Y. A. Minamishima,et al. Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells. , 2001, Cancer genetics and cytogenetics.
[9] G. Auer,et al. Human Papillomavirus Infection, Centrosome Aberration, and Genetic Stability in Cervical Lesions , 2001, Modern Pathology.
[10] L. Liotta,et al. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. , 2001, Cancer research.
[11] D J O'Kane,et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. , 2000, The Journal of urology.
[12] R. Jenkins,et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. , 2000, The Journal of molecular diagnostics : JMD.
[13] Jonathan J Ross,et al. Ancillary methods for the detection of recurrent urothelial neoplasia , 2000, Cancer.
[14] E. Schröck,et al. Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations , 2000, Genes, chromosomes & cancer.
[15] C. Ker,et al. Centrosome abnormalities in human carcinomas of the gallbladder and intrahepatic and extrahepatic bile ducts , 2000, Hepatology.
[16] W. Lingle,et al. Altered centrosome structure is associated with abnormal mitoses in human breast tumors. , 1999, The American journal of pathology.
[17] Masafumi Nakamura,et al. Centrosome abnormalities in pancreatic ductal carcinoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] H. Mori,et al. Centrosomal kinase AIK1 is overexpressed in invasive ductal carcinoma of the breast. , 1999, Cancer research.
[19] P. Duesberg,et al. Genetic instability of cancer cells is proportional to their degree of aneuploidy. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[20] Jian Kuang,et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation , 1998, Nature Genetics.
[21] H Knecht,et al. Centrosome defects and genetic instability in malignant tumors. , 1998, Cancer research.
[22] J. Ingle,et al. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[23] R. Katz,et al. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer , 1998, Oncogene.
[24] H. Moch,et al. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. , 1997, Cancer research.
[25] D. Johnston,et al. DNA image analysis of urinary cytology: prediction of recurrent transitional cell carcinoma. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[26] R.C.E. van Velthoven,et al. Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas. , 1995, Human pathology.
[27] Th. Boveri,et al. The origin of malignant tumors , 1929 .